UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BRAF V600E Inhibition in Anaplastic Thyroid Cancer

The New England journal of medicine, 2013-02, Vol.368 (7), p.684-685

2013

Volltextzugriff (PDF)

Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer

Future oncology (London, England), 2013-03, Vol.9 (3), p.319-326

2013

Volltextzugriff (PDF)

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

Therapeutic Advances in Medical Oncology, 2014-09, Vol.6 (5), p.202-209

2014

Volltextzugriff (PDF)

Triple negative breast cancer: any closer to cracking the code?

Current opinion in obstetrics & gynecology, 2022-02, Vol.34 (1), p.52-55

Peddi, Parvin F

2022

Volltextzugriff (PDF)

Management of Breast Sarcoma

The Surgical clinics of North America, 2016-10, Vol.96 (5), p.1047-1058

2016

Volltextzugriff (PDF)

Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

International Journal of Breast Cancer, 2012-01, Vol.2012 (2012), p.64-70

2012

Volltextzugriff (PDF)

Hormone receptor positive breast cancer: state of the art

Current opinion in obstetrics & gynecology, 2018-02, Vol.30 (1), p.51-54

Peddi, Parvin F.

2018

Volltextzugriff (PDF)

AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer

Journal of clinical oncology, 2023-08, Vol.41 (24), p.4014-4024

2023

Volltextzugriff (PDF)

Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920967259-1758835920967259

2020

Volltextzugriff (PDF)

Frontiers in HER2-positive breast cancer in 2020

Current opinion in obstetrics & gynecology, 2021-02, Vol.33 (1), p.48-52

2021

Volltextzugriff (PDF)

Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer

Clinical cancer research, 2022-05, Vol.28 (9), p.1854-1862

2022

Volltextzugriff (PDF)

Central nervous system toxicities of chemotherapeutic agents

Expert review of anticancer therapy, 2014-07, Vol.14 (7), p.857-863

2014

Volltextzugriff (PDF)

Fertility after breast cancer treatment

European journal of obstetrics & gynecology and reproductive biology, 2014-02, Vol.173, p.13-18

2014

Volltextzugriff (PDF)

Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma

Journal of translational medicine, 2013-09, Vol.11 (1), p.206-206, Article 206

2013

Volltextzugriff (PDF)

Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma

Journal of the Pancreas, 2012-09, Vol.13 (5), p.497

2012

Volltextzugriff (PDF)

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

Journal of neuro-oncology, 2014-03, Vol.117 (1), p.7-13

2014

Volltextzugriff (PDF)

Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer

Cancer treatment reviews, 2014-03, Vol.40 (2), p.320-326

2014

Volltextzugriff (PDF)

A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Clinical colorectal cancer, 2013-12, Vol.12 (4), p.248-254

2013

Volltextzugriff (PDF)

Successful resection after neoadjuvant therapy in pancreatic adenocarcinoma

Journal of the National Comprehensive Cancer Network, 2012-11, Vol.10 (11), p.1330-1334

2012

Volltextzugriff (PDF)

Impact of a Palliative Care Nurse Practitioner in an Oncology Clinic: A Quality Improvement Effort

JCO oncology practice, 2022-04, Vol.18 (4), p.e484-e494

2022

Volltextzugriff (PDF)

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma

Journal of gastrointestinal oncology, 2013-12, Vol.4 (4), p.370-373

2013

Volltextzugriff (PDF)

Integration of breast-oncology clinical pathways in Providence Southern California clinical research network

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18710-e18710

2023

Volltextzugriff (PDF)

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS603-TPS603

2021

Volltextzugriff (PDF)

Implementation and dissemination of a shared mental model of palliative oncology

Journal of clinical oncology, 2019-11, Vol.37 (31_suppl), p.58-58

2019

Volltextzugriff (PDF)

Dissemination of breast cancer knowledge and expertise from NCI-CCC tumor boards with community oncologists

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18575-e18575

2018

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(30)
Berichte
(1)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

BRAF V600E Inhibition in Anaplastic Thyroid Cancer

Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

Triple negative breast cancer: any closer to cracking the code?

Management of Breast Sarcoma

Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

Hormone receptor positive breast cancer: state of the art

AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer

Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

Frontiers in HER2-positive breast cancer in 2020

Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer

Central nervous system toxicities of chemotherapeutic agents

Fertility after breast cancer treatment

Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma

Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer

A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Successful resection after neoadjuvant therapy in pancreatic adenocarcinoma

Impact of a Palliative Care Nurse Practitioner in an Oncology Clinic: A Quality Improvement Effort

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma

Integration of breast-oncology clinical pathways in Providence Southern California clinical research network

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

Implementation and dissemination of a shared mental model of palliative oncology

Dissemination of breast cancer knowledge and expertise from NCI-CCC tumor boards with community oncologists

Suchergebnisse filtern